カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のムピロシン市場2022年：クリーム、軟膏、その他

◆英語タイトル：Global Mupirocin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8898 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：112 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ムピロシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のムピロシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ムピロシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・クリーム、軟膏、その他

用途別セグメントは次のように区分されます。
・一次感染、二次感染

世界のムピロシン市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Medimetriks Pharmaceuticals、Cardinal Health、Ortho-McNeil Pharmaceutical、Glenmark Pharmaceuticals、Taro Pharmaceuticals、BIOMES PHARMACEUTICALS、H.J. Harkins Company、Directrx、Teva Pharmaceuticals、Fougera Pharmaceuticals、Profcient、Remedy Repack、Lohxa、Nucare Pharmaceuticals、Sino-american Tianjin Shike Pharmaceutical、Hangzhou Zhuyangxin Pharmaceutical、Hubei Renfu Chengtian Pharmaceutical、Hong Kong Aomei Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ムピロシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なムピロシンメーカーの企業概要、2019年～2022年までのムピロシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なムピロシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ムピロシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのムピロシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのムピロシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびムピロシンの産業チェーンを掲載しています。
・第13、14、15章では、ムピロシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GSK、Medimetriks Pharmaceuticals、Cardinal Health、Ortho-McNeil Pharmaceutical、Glenmark Pharmaceuticals、Taro Pharmaceuticals、BIOMES PHARMACEUTICALS、H.J. Harkins Company、Directrx、Teva Pharmaceuticals、Fougera Pharmaceuticals、Profcient、Remedy Repack、Lohxa、Nucare Pharmaceuticals、Sino-american Tianjin Shike Pharmaceutical、Hangzhou Zhuyangxin Pharmaceutical、Hubei Renfu Chengtian Pharmaceutical、Hong Kong Aomei Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：クリーム、軟膏、その他
・用途別分析2017年-2028年：一次感染、二次感染
・ムピロシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ムピロシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ムピロシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ムピロシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ムピロシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Mupirocin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Mupirocin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Primary Infection accounting for % of the Mupirocin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cream segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Mupirocin include GSK, Medimetriks Pharmaceuticals, Cardinal Health, Ortho-McNeil Pharmaceutical, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mupirocin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cream
Ointment
Other
Market segment by Application can be divided into
Primary Infection
Secondary Infection
The key market players for global Mupirocin market are listed below:
GSK
Medimetriks Pharmaceuticals
Cardinal Health
Ortho-McNeil Pharmaceutical
Glenmark Pharmaceuticals
Taro Pharmaceuticals
BIOMES PHARMACEUTICALS
H.J. Harkins Company
Directrx
Teva Pharmaceuticals
Fougera Pharmaceuticals
Profcient
Remedy Repack
Lohxa
Nucare Pharmaceuticals
Sino-american Tianjin Shike Pharmaceutical
Hangzhou Zhuyangxin Pharmaceutical
Hubei Renfu Chengtian Pharmaceutical
Hong Kong Aomei Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mupirocin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mupirocin, with price, sales, revenue and global market share of Mupirocin from 2019 to 2022.
Chapter 3, the Mupirocin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mupirocin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mupirocin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mupirocin.
Chapter 13, 14, and 15, to describe Mupirocin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Mupirocin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mupirocin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cream
1.2.3 Ointment
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Mupirocin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Primary Infection
1.3.3 Secondary Infection
1.4 Global Mupirocin Market Size & Forecast
1.4.1 Global Mupirocin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mupirocin Sales in Volume (2017-2028)
1.4.3 Global Mupirocin Price (2017-2028)
1.5 Global Mupirocin Production Capacity Analysis
1.5.1 Global Mupirocin Total Production Capacity (2017-2028)
1.5.2 Global Mupirocin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mupirocin Market Drivers
1.6.2 Mupirocin Market Restraints
1.6.3 Mupirocin Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Mupirocin Product and Services
2.1.4 GSK Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medimetriks Pharmaceuticals
2.2.1 Medimetriks Pharmaceuticals Details
2.2.2 Medimetriks Pharmaceuticals Major Business
2.2.3 Medimetriks Pharmaceuticals Mupirocin Product and Services
2.2.4 Medimetriks Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cardinal Health
2.3.1 Cardinal Health Details
2.3.2 Cardinal Health Major Business
2.3.3 Cardinal Health Mupirocin Product and Services
2.3.4 Cardinal Health Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ortho-McNeil Pharmaceutical
2.4.1 Ortho-McNeil Pharmaceutical Details
2.4.2 Ortho-McNeil Pharmaceutical Major Business
2.4.3 Ortho-McNeil Pharmaceutical Mupirocin Product and Services
2.4.4 Ortho-McNeil Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Mupirocin Product and Services
2.5.4 Glenmark Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Taro Pharmaceuticals
2.6.1 Taro Pharmaceuticals Details
2.6.2 Taro Pharmaceuticals Major Business
2.6.3 Taro Pharmaceuticals Mupirocin Product and Services
2.6.4 Taro Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 BIOMES PHARMACEUTICALS
2.7.1 BIOMES PHARMACEUTICALS Details
2.7.2 BIOMES PHARMACEUTICALS Major Business
2.7.3 BIOMES PHARMACEUTICALS Mupirocin Product and Services
2.7.4 BIOMES PHARMACEUTICALS Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 H.J. Harkins Company
2.8.1 H.J. Harkins Company Details
2.8.2 H.J. Harkins Company Major Business
2.8.3 H.J. Harkins Company Mupirocin Product and Services
2.8.4 H.J. Harkins Company Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Directrx
2.9.1 Directrx Details
2.9.2 Directrx Major Business
2.9.3 Directrx Mupirocin Product and Services
2.9.4 Directrx Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceuticals
2.10.1 Teva Pharmaceuticals Details
2.10.2 Teva Pharmaceuticals Major Business
2.10.3 Teva Pharmaceuticals Mupirocin Product and Services
2.10.4 Teva Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Fougera Pharmaceuticals
2.11.1 Fougera Pharmaceuticals Details
2.11.2 Fougera Pharmaceuticals Major Business
2.11.3 Fougera Pharmaceuticals Mupirocin Product and Services
2.11.4 Fougera Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Profcient
2.12.1 Profcient Details
2.12.2 Profcient Major Business
2.12.3 Profcient Mupirocin Product and Services
2.12.4 Profcient Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Remedy Repack
2.13.1 Remedy Repack Details
2.13.2 Remedy Repack Major Business
2.13.3 Remedy Repack Mupirocin Product and Services
2.13.4 Remedy Repack Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lohxa
2.14.1 Lohxa Details
2.14.2 Lohxa Major Business
2.14.3 Lohxa Mupirocin Product and Services
2.14.4 Lohxa Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Nucare Pharmaceuticals
2.15.1 Nucare Pharmaceuticals Details
2.15.2 Nucare Pharmaceuticals Major Business
2.15.3 Nucare Pharmaceuticals Mupirocin Product and Services
2.15.4 Nucare Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sino-american Tianjin Shike Pharmaceutical
2.16.1 Sino-american Tianjin Shike Pharmaceutical Details
2.16.2 Sino-american Tianjin Shike Pharmaceutical Major Business
2.16.3 Sino-american Tianjin Shike Pharmaceutical Mupirocin Product and Services
2.16.4 Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Hangzhou Zhuyangxin Pharmaceutical
2.17.1 Hangzhou Zhuyangxin Pharmaceutical Details
2.17.2 Hangzhou Zhuyangxin Pharmaceutical Major Business
2.17.3 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product and Services
2.17.4 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Hubei Renfu Chengtian Pharmaceutical
2.18.1 Hubei Renfu Chengtian Pharmaceutical Details
2.18.2 Hubei Renfu Chengtian Pharmaceutical Major Business
2.18.3 Hubei Renfu Chengtian Pharmaceutical Mupirocin Product and Services
2.18.4 Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Hong Kong Aomei Pharmaceutical
2.19.1 Hong Kong Aomei Pharmaceutical Details
2.19.2 Hong Kong Aomei Pharmaceutical Major Business
2.19.3 Hong Kong Aomei Pharmaceutical Mupirocin Product and Services
2.19.4 Hong Kong Aomei Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mupirocin Breakdown Data by Manufacturer
3.1 Global Mupirocin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mupirocin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mupirocin
3.4 Market Concentration Rate
3.4.1 Top 3 Mupirocin Manufacturer Market Share in 2021
3.4.2 Top 6 Mupirocin Manufacturer Market Share in 2021
3.5 Global Mupirocin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mupirocin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mupirocin Market Size by Region
4.1.1 Global Mupirocin Sales in Volume by Region (2017-2028)
4.1.2 Global Mupirocin Revenue by Region (2017-2028)
4.2 North America Mupirocin Revenue (2017-2028)
4.3 Europe Mupirocin Revenue (2017-2028)
4.4 Asia-Pacific Mupirocin Revenue (2017-2028)
4.5 South America Mupirocin Revenue (2017-2028)
4.6 Middle East and Africa Mupirocin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mupirocin Sales in Volume by Type (2017-2028)
5.2 Global Mupirocin Revenue by Type (2017-2028)
5.3 Global Mupirocin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mupirocin Sales in Volume by Application (2017-2028)
6.2 Global Mupirocin Revenue by Application (2017-2028)
6.3 Global Mupirocin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mupirocin Sales by Type (2017-2028)
7.2 North America Mupirocin Sales by Application (2017-2028)
7.3 North America Mupirocin Market Size by Country
7.3.1 North America Mupirocin Sales in Volume by Country (2017-2028)
7.3.2 North America Mupirocin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mupirocin Sales by Type (2017-2028)
8.2 Europe Mupirocin Sales by Application (2017-2028)
8.3 Europe Mupirocin Market Size by Country
8.3.1 Europe Mupirocin Sales in Volume by Country (2017-2028)
8.3.2 Europe Mupirocin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mupirocin Sales by Type (2017-2028)
9.2 Asia-Pacific Mupirocin Sales by Application (2017-2028)
9.3 Asia-Pacific Mupirocin Market Size by Region
9.3.1 Asia-Pacific Mupirocin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mupirocin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mupirocin Sales by Type (2017-2028)
10.2 South America Mupirocin Sales by Application (2017-2028)
10.3 South America Mupirocin Market Size by Country
10.3.1 South America Mupirocin Sales in Volume by Country (2017-2028)
10.3.2 South America Mupirocin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mupirocin Sales by Type (2017-2028)
11.2 Middle East & Africa Mupirocin Sales by Application (2017-2028)
11.3 Middle East & Africa Mupirocin Market Size by Country
11.3.1 Middle East & Africa Mupirocin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mupirocin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mupirocin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mupirocin
12.3 Mupirocin Production Process
12.4 Mupirocin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mupirocin Typical Distributors
13.3 Mupirocin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Mupirocin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Mupirocin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Mupirocin Product and Services
Table 6. GSK Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Medimetriks Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Medimetriks Pharmaceuticals Major Business
Table 9. Medimetriks Pharmaceuticals Mupirocin Product and Services
Table 10. Medimetriks Pharmaceuticals Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 12. Cardinal Health Major Business
Table 13. Cardinal Health Mupirocin Product and Services
Table 14. Cardinal Health Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ortho-McNeil Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Ortho-McNeil Pharmaceutical Major Business
Table 17. Ortho-McNeil Pharmaceutical Mupirocin Product and Services
Table 18. Ortho-McNeil Pharmaceutical Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Glenmark Pharmaceuticals Major Business
Table 21. Glenmark Pharmaceuticals Mupirocin Product and Services
Table 22. Glenmark Pharmaceuticals Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Taro Pharmaceuticals Major Business
Table 25. Taro Pharmaceuticals Mupirocin Product and Services
Table 26. Taro Pharmaceuticals Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. BIOMES PHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 28. BIOMES PHARMACEUTICALS Major Business
Table 29. BIOMES PHARMACEUTICALS Mupirocin Product and Services
Table 30. BIOMES PHARMACEUTICALS Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. H.J. Harkins Company Basic Information, Manufacturing Base and Competitors
Table 32. H.J. Harkins Company Major Business
Table 33. H.J. Harkins Company Mupirocin Product and Services
Table 34. H.J. Harkins Company Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Directrx Basic Information, Manufacturing Base and Competitors
Table 36. Directrx Major Business
Table 37. Directrx Mupirocin Product and Services
Table 38. Directrx Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceuticals Major Business
Table 41. Teva Pharmaceuticals Mupirocin Product and Services
Table 42. Teva Pharmaceuticals Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Fougera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Fougera Pharmaceuticals Major Business
Table 45. Fougera Pharmaceuticals Mupirocin Product and Services
Table 46. Fougera Pharmaceuticals Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Profcient Basic Information, Manufacturing Base and Competitors
Table 48. Profcient Major Business
Table 49. Profcient Mupirocin Product and Services
Table 50. Profcient Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Remedy Repack Basic Information, Manufacturing Base and Competitors
Table 52. Remedy Repack Major Business
Table 53. Remedy Repack Mupirocin Product and Services
Table 54. Remedy Repack Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Lohxa Basic Information, Manufacturing Base and Competitors
Table 56. Lohxa Major Business
Table 57. Lohxa Mupirocin Product and Services
Table 58. Lohxa Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Nucare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Nucare Pharmaceuticals Major Business
Table 61. Nucare Pharmaceuticals Mupirocin Product and Services
Table 62. Nucare Pharmaceuticals Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Sino-american Tianjin Shike Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Sino-american Tianjin Shike Pharmaceutical Major Business
Table 65. Sino-american Tianjin Shike Pharmaceutical Mupirocin Product and Services
Table 66. Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Hangzhou Zhuyangxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hangzhou Zhuyangxin Pharmaceutical Major Business
Table 69. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product and Services
Table 70. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Hubei Renfu Chengtian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Hubei Renfu Chengtian Pharmaceutical Major Business
Table 73. Hubei Renfu Chengtian Pharmaceutical Mupirocin Product and Services
Table 74. Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Hong Kong Aomei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Hong Kong Aomei Pharmaceutical Major Business
Table 77. Hong Kong Aomei Pharmaceutical Mupirocin Product and Services
Table 78. Hong Kong Aomei Pharmaceutical Mupirocin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Mupirocin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KG)
Table 80. Global Mupirocin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Mupirocin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Mupirocin Production Capacity by Company, (KG): 2020 VS 2021
Table 83. Head Office and Mupirocin Production Site of Key Manufacturer
Table 84. Mupirocin New Entrant and Capacity Expansion Plans
Table 85. Mupirocin Mergers & Acquisitions in the Past Five Years
Table 86. Global Mupirocin Sales by Region (2017-2022) & (KG)
Table 87. Global Mupirocin Sales by Region (2023-2028) & (KG)
Table 88. Global Mupirocin Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Mupirocin Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Mupirocin Sales by Type (2017-2022) & (KG)
Table 91. Global Mupirocin Sales by Type (2023-2028) & (KG)
Table 92. Global Mupirocin Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Mupirocin Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Mupirocin Price by Type (2017-2022) & (US$/G)
Table 95. Global Mupirocin Price by Type (2023-2028) & (US$/G)
Table 96. Global Mupirocin Sales by Application (2017-2022) & (KG)
Table 97. Global Mupirocin Sales by Application (2023-2028) & (KG)
Table 98. Global Mupirocin Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Mupirocin Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Mupirocin Price by Application (2017-2022) & (US$/G)
Table 101. Global Mupirocin Price by Application (2023-2028) & (US$/G)
Table 102. North America Mupirocin Sales by Country (2017-2022) & (KG)
Table 103. North America Mupirocin Sales by Country (2023-2028) & (KG)
Table 104. North America Mupirocin Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Mupirocin Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Mupirocin Sales by Type (2017-2022) & (KG)
Table 107. North America Mupirocin Sales by Type (2023-2028) & (KG)
Table 108. North America Mupirocin Sales by Application (2017-2022) & (KG)
Table 109. North America Mupirocin Sales by Application (2023-2028) & (KG)
Table 110. Europe Mupirocin Sales by Country (2017-2022) & (KG)
Table 111. Europe Mupirocin Sales by Country (2023-2028) & (KG)
Table 112. Europe Mupirocin Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Mupirocin Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Mupirocin Sales by Type (2017-2022) & (KG)
Table 115. Europe Mupirocin Sales by Type (2023-2028) & (KG)
Table 116. Europe Mupirocin Sales by Application (2017-2022) & (KG)
Table 117. Europe Mupirocin Sales by Application (2023-2028) & (KG)
Table 118. Asia-Pacific Mupirocin Sales by Region (2017-2022) & (KG)
Table 119. Asia-Pacific Mupirocin Sales by Region (2023-2028) & (KG)
Table 120. Asia-Pacific Mupirocin Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Mupirocin Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Mupirocin Sales by Type (2017-2022) & (KG)
Table 123. Asia-Pacific Mupirocin Sales by Type (2023-2028) & (KG)
Table 124. Asia-Pacific Mupirocin Sales by Application (2017-2022) & (KG)
Table 125. Asia-Pacific Mupirocin Sales by Application (2023-2028) & (KG)
Table 126. South America Mupirocin Sales by Country (2017-2022) & (KG)
Table 127. South America Mupirocin Sales by Country (2023-2028) & (KG)
Table 128. South America Mupirocin Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Mupirocin Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Mupirocin Sales by Type (2017-2022) & (KG)
Table 131. South America Mupirocin Sales by Type (2023-2028) & (KG)
Table 132. South America Mupirocin Sales by Application (2017-2022) & (KG)
Table 133. South America Mupirocin Sales by Application (2023-2028) & (KG)
Table 134. Middle East & Africa Mupirocin Sales by Region (2017-2022) & (KG)
Table 135. Middle East & Africa Mupirocin Sales by Region (2023-2028) & (KG)
Table 136. Middle East & Africa Mupirocin Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Mupirocin Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Mupirocin Sales by Type (2017-2022) & (KG)
Table 139. Middle East & Africa Mupirocin Sales by Type (2023-2028) & (KG)
Table 140. Middle East & Africa Mupirocin Sales by Application (2017-2022) & (KG)
Table 141. Middle East & Africa Mupirocin Sales by Application (2023-2028) & (KG)
Table 142. Mupirocin Raw Material
Table 143. Key Manufacturers of Mupirocin Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Mupirocin Typical Distributors
Table 147. Mupirocin Typical Customers
List of Figures
Figure 1. Mupirocin Picture
Figure 2. Global Mupirocin Revenue Market Share by Type in 2021
Figure 3. Cream
Figure 4. Ointment
Figure 5. Other
Figure 6. Global Mupirocin Revenue Market Share by Application in 2021
Figure 7. Primary Infection
Figure 8. Secondary Infection
Figure 9. Global Mupirocin Revenue, (USD Million) & (KG): 2017 & 2021 & 2028
Figure 10. Global Mupirocin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Mupirocin Sales (2017-2028) & (KG)
Figure 12. Global Mupirocin Price (2017-2028) & (US$/G)
Figure 13. Global Mupirocin Production Capacity (2017-2028) & (KG)
Figure 14. Global Mupirocin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Mupirocin Market Drivers
Figure 16. Mupirocin Market Restraints
Figure 17. Mupirocin Market Trends
Figure 18. Global Mupirocin Sales Market Share by Manufacturer in 2021
Figure 19. Global Mupirocin Revenue Market Share by Manufacturer in 2021
Figure 20. Mupirocin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Mupirocin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Mupirocin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Mupirocin Sales Market Share by Region (2017-2028)
Figure 24. Global Mupirocin Revenue Market Share by Region (2017-2028)
Figure 25. North America Mupirocin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Mupirocin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Mupirocin Revenue (2017-2028) & (USD Million)
Figure 28. South America Mupirocin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Mupirocin Revenue (2017-2028) & (USD Million)
Figure 30. Global Mupirocin Sales Market Share by Type (2017-2028)
Figure 31. Global Mupirocin Revenue Market Share by Type (2017-2028)
Figure 32. Global Mupirocin Price by Type (2017-2028) & (US$/G)
Figure 33. Global Mupirocin Sales Market Share by Application (2017-2028)
Figure 34. Global Mupirocin Revenue Market Share by Application (2017-2028)
Figure 35. Global Mupirocin Price by Application (2017-2028) & (US$/G)
Figure 36. North America Mupirocin Sales Market Share by Type (2017-2028)
Figure 37. North America Mupirocin Sales Market Share by Application (2017-2028)
Figure 38. North America Mupirocin Sales Market Share by Country (2017-2028)
Figure 39. North America Mupirocin Revenue Market Share by Country (2017-2028)
Figure 40. United States Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Mupirocin Sales Market Share by Type (2017-2028)
Figure 44. Europe Mupirocin Sales Market Share by Application (2017-2028)
Figure 45. Europe Mupirocin Sales Market Share by Country (2017-2028)
Figure 46. Europe Mupirocin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Mupirocin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Mupirocin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Mupirocin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Mupirocin Revenue Market Share by Region (2017-2028)
Figure 56. China Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Mupirocin Sales Market Share by Type (2017-2028)
Figure 63. South America Mupirocin Sales Market Share by Application (2017-2028)
Figure 64. South America Mupirocin Sales Market Share by Country (2017-2028)
Figure 65. South America Mupirocin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Mupirocin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Mupirocin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Mupirocin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Mupirocin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Mupirocin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Mupirocin in 2021
Figure 77. Manufacturing Process Analysis of Mupirocin
Figure 78. Mupirocin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のムピロシン市場2022年：クリーム、軟膏、その他(Global Mupirocin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のムピロシン市場2022年：クリーム、軟膏、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp